Tiziana commences Phase Ib trial of Crohn’s disease antibody
The safety and tolerability of the oral enteric-coated capsules of foralumab is the primary objective of the trial.
United Kingdom
Latest in
United Kingdom
Urgent need for endometriosis awareness as diagnosis lags behind in the UK
GlobalData epidemiologists expect diagnosed prevalent cases of endometriosis in the UK to increase over the next five years.
By
TC BioPharm to initiate Phase IIb/III trial of AML allogeneic cell therapy
OmnImmune is an allogeneic unmodified cell therapy and comprises activated and extended gamma delta T cells.
Freeline Therapeutics doses first subject in haemophilia B therapy trial
The study will use an initial 7.7e11vg/kg dose and a short course of prophylactic immune management to normalise FIX levels.
Parkinson’s disease: can an early phase live biotherapeutic make waves?
4D Pharma gives Clinical Trials Arena a preview of its potential Phase I Parkinson’s trial design.
By
Synairgen’s Phase III trial in hospitalised Covid-19 fails to meet endpoints
An inhaled formulation, SNG001 contains the broad-spectrum antiviral protein interferon beta.
UK MHRA approves Skymount trial for AI-discovered Covid-19 therapeutics
In cell and animal studies, the two-drug combination showed to decrease SARS-CoV-2 viral load.
Impact of cervical cancer screening policy changes in the UK could be minimal
There are concerns increasing numbers of women missing cervical cancer screening could negate diagnostic accuracy improvements.
By